800 related articles for article (PubMed ID: 26699999)
1. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
[TBL] [Abstract][Full Text] [Related]
2. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
[TBL] [Abstract][Full Text] [Related]
3. Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis.
Okada K; Kakeda S; Tahara M
Mult Scler Relat Disord; 2020 Feb; 38():101507. PubMed ID: 31766000
[TBL] [Abstract][Full Text] [Related]
4. Olfactory bulb and olfactory sulcus depths are associated with disease duration and attack frequency in multiple sclerosis patients.
Tanik N; Serin HI; Celikbilek A; Inan LE; Gundogdu F
J Neurol Sci; 2015 Nov; 358(1-2):304-7. PubMed ID: 26384615
[TBL] [Abstract][Full Text] [Related]
5. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
6. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
7. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
8. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
D'Ambrosio A; Pagani E; Riccitelli GC; Colombo B; Rodegher M; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2017 Aug; 23(9):1194-1203. PubMed ID: 27760859
[TBL] [Abstract][Full Text] [Related]
9. Olfactory bulb volume and olfactory function in patients with multiple sclerosis.
Goektas O; Schmidt F; Bohner G; Erb K; Ludemann L; Dahlslett B; Harms L; Fleiner F
Rhinology; 2011 Jun; 49(2):221-6. PubMed ID: 21743881
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study.
Matsushita F; Kida H; Tabei KI; Nakano C; Matsuura K; Ii Y; Sasaki R; Taniguchi A; Narita Y; Maeda M; Satoh M; Tomimoto H
Brain Behav; 2018 Mar; 8(3):e00934. PubMed ID: 29541544
[TBL] [Abstract][Full Text] [Related]
11. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
[TBL] [Abstract][Full Text] [Related]
12. Cortical lesion load associates with progression of disability in multiple sclerosis.
Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
[TBL] [Abstract][Full Text] [Related]
13. Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
Harrison DM; Roy S; Oh J; Izbudak I; Pham D; Courtney S; Caffo B; Jones CK; van Zijl P; Calabresi PA
JAMA Neurol; 2015 Sep; 72(9):1004-12. PubMed ID: 26192316
[TBL] [Abstract][Full Text] [Related]
14. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
Megna R; Alfano B; Lanzillo R; Costabile T; Comerci M; Vacca G; Carotenuto A; Moccia M; Servillo G; Prinster A; Brescia Morra V; Quarantelli M
J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
[TBL] [Abstract][Full Text] [Related]
15. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
[TBL] [Abstract][Full Text] [Related]
16. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A
Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
18. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume.
Karlińska I; Siger M; Lewańska M; Selmaj K
Neurol Neurochir Pol; 2008; 42(5):416-23. PubMed ID: 19105110
[TBL] [Abstract][Full Text] [Related]
20. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
